hydrochlorothiazide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

hydrochlorothiazide has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Branciforte, L; Bucca, C; Bugiani, M; Oliva, A; Rolla, G1

Other Studies

1 other study(ies) available for hydrochlorothiazide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Hypomagnesemia in chronic obstructive lung disease: effect of therapy.
    Magnesium and trace elements, 1990, Volume: 9, Issue:3

    Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Beclomethasone; Diuretics; Female; Furosemide; Humans; Hydrochlorothiazide; Lung Diseases, Obstructive; Magnesium; Magnesium Deficiency; Male; Methylprednisolone; Middle Aged; Theophylline

1990